Angiography Device Market Size, Share, Growth, and Industry Analysis, By Type (X-Ray Angiography Devices,CT Angiography Devices,MR Angiography Devices), By Application (Diagnostic,Therapeutic), Regional Insights and Forecast to 2035

Angiography Device Market Overview

The global Angiography Device Market size is projected to grow from USD 12252.3 million in 2026 to USD 12632.12 million in 2027, reaching USD 16126.7 million by 2035, expanding at a CAGR of 3.1% during the forecast period.

The Angiography Device Market plays a critical role in the global healthcare industry, driven by the growing burden of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Globally, cardiovascular diseases are responsible for over 17.9 million deaths annually, representing nearly 32% of all deaths worldwide. This alarming number has significantly increased the demand for angiography devices used for diagnosis and treatment planning. In 2024, more than 7,500 hospitals worldwide were equipped with advanced angiography systems, and over 60% of tertiary hospitals in developed economies have at least one digital angiography suite. The market is dominated by technologically advanced systems offering high spatial resolution and low radiation exposure, enhancing clinical accuracy by up to 45% compared to conventional methods. Manufacturers are increasingly focusing on AI-integrated angiography devices capable of improving lesion detection rates by 30–40%, reducing procedure times by 25%, and lowering contrast media usage by 20%. Additionally, 3D and hybrid imaging are transforming cardiovascular diagnostics, with 3D angiography accounting for approximately 22% of global installations in 2024. Hospitals account for nearly 68% of the total market share, followed by diagnostic imaging centers with 24%, and ambulatory surgical centers contributing around 8%. Increasing emphasis on minimally invasive procedures has resulted in over 55% of interventional cardiologists adopting advanced digital angiography systems for real-time guidance. Emerging economies are showing rapid adoption rates due to healthcare infrastructure development. Asia-Pacific, for example, installed over 1,200 new angiography systems in 2024 alone. Furthermore, ongoing government initiatives aimed at early diagnosis of coronary artery disease (CAD) and stroke have boosted the installation base across both public and private healthcare institutions. The Angiography Device Market Research Report indicates steady technological innovation, with an estimated 42% of systems upgraded annually for software and imaging performance enhancements.

The United States represents one of the largest and most technologically advanced markets for angiography devices. In 2024, the U.S. accounted for approximately 31% of the global market share. The country has more than 1,900 operational cardiac catheterization laboratories, with over 70% utilizing flat-panel digital angiography systems. The prevalence of cardiovascular diseases in the U.S. exceeds 48% among adults aged 50 years and above, which directly drives demand for diagnostic and interventional angiography. Each year, an estimated 1.3 million coronary angiograms are performed in U.S. hospitals. The rise in minimally invasive procedures and outpatient cardiac care centers has also boosted system installations, with more than 400 new angiography units added in 2024. Technological advancements, such as robotic-assisted angiography and low-dose imaging technology, have improved patient outcomes and operational efficiency. The integration of AI-based image enhancement has resulted in up to 35% faster diagnosis times and 28% better lesion visibility. The U.S. angiography device market continues to expand due to high healthcare spending and the increasing adoption of hybrid cath lab solutions in hospitals across major cities, including New York, Chicago, and Los Angeles.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: Rising cardiovascular disease prevalence drives demand, with 85% of angiography system installations occurring in cardiology departments.
• Major Market Restraint: High equipment cost remains a key barrier, with around 55% of small healthcare facilities delaying upgrades.
• Emerging Trends: Approximately 50% of manufacturers are integrating AI-based image enhancement in angiography devices.
• Regional Leadership: North America leads with nearly 38% of the global market share, followed by Europe at 30%.
• Competitive Landscape: The top five players hold around 60% of the total market share.
• Market Segmentation: Cardiac angiography dominates with 68% of overall procedures.
• Recent Development: Over 35% of angiography product launches in the past two years featured AI-enabled functionalities.

Angiography Device Market Trends

The Angiography Device Market Trends demonstrate an evolving landscape dominated by digital transformation, minimally invasive procedures, and precision imaging. The adoption of flat-panel detector angiography systems has increased by 41% over the last five years due to their superior image clarity and reduced radiation exposure. Hybrid operating rooms—integrating angiography with surgical and imaging capabilities—have expanded by 36% globally between 2020 and 2024. One of the most significant market trends is the integration of artificial intelligence (AI) for image interpretation, lesion detection, and workflow automation. AI-enabled systems can reduce diagnostic time by up to 40% and improve procedural efficiency by 33%. The introduction of 3D and 4D angiography imaging has revolutionized visualization, offering enhanced precision during complex cardiac interventions. Approximately 30% of hospitals worldwide have now adopted 3D imaging technology for cardiovascular and neurovascular angiography. Another key trend is the shift toward portable and compact angiography systems, which account for nearly 18% of installations globally. These mobile systems support emergency and trauma applications, especially in field hospitals and smaller diagnostic centers.

Furthermore, integration with hospital information systems and real-time data sharing between imaging and surgical teams has increased interoperability by 25% across healthcare facilities. The demand for low-dose radiation systems continues to grow due to rising awareness of radiation safety. New devices can lower exposure by 45–55% compared to older models while maintaining image quality. In addition, demand for contrast-reducing technologies has increased, as approximately 12% of patients undergoing angiography face contrast-induced nephropathy risks. The growing prevalence of chronic diseases, coupled with the aging population—expected to reach 1.4 billion individuals over 60 years old by 2030—further accelerates the demand for angiography equipment. As the healthcare sector prioritizes faster and more accurate diagnostics, the Angiography Device Market Analysis indicates strong potential for continued technological innovation and widespread adoption.

Angiography Device Market Dynamics

DRIVER

"Rising incidence of cardiovascular and cerebrovascular diseases"

Globally, more than 520 million people are living with cardiovascular conditions, significantly driving the need for angiographic diagnostics.

RESTRAINT

"Limited access and high equipment cost"

The high installation cost of angiography systems—ranging from $300,000 to $1 million per unit—restricts adoption in small and mid-sized healthcare facilities.

OPPORTUNITY

"Expansion of minimally invasive and AI-powered angiography solutions"

The global trend toward non-invasive procedures has led to a 45% increase in demand for AI-integrated angiography systems that enhance accuracy and reduce procedure time.

CHALLENGE

"Technical complexity and skilled workforce shortages"

Over 30% of healthcare institutions report shortages of skilled technicians and interventional radiologists trained in advanced angiography techniques.

Angiography Device Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

X-Ray Angiography Devices: dominates the market, representing around 37% of total installations. These systems are widely used in hospitals for coronary and peripheral angiographic procedures. Continuous improvements in flat-panel detectors and image processing have enhanced visualization quality by 45% while minimizing radiation exposure by 50%.

The X-Ray Angiography Devices segment is anticipated to reach a market value of USD 5,612.4 million in 2025, growing to USD 7,062.5 million by 2034, registering a CAGR of 2.6% and accounting for approximately 47.2% of the total market share.

Top 5 Major Dominant Countries in the X-Ray Angiography Devices Segment:

• United States: Leads with a market size of USD 1,895.3 million in 2025, projected to reach USD 2,378.1 million by 2034, expanding at a CAGR of 2.7%.
• Germany: Holds a USD 672.4 million market in 2025, expected to grow to USD 855.9 million by 2034, recording a CAGR of 2.8%.
• Japan: Accounts for USD 618.2 million in 2025, estimated to reach USD 787.6 million by 2034, with a steady CAGR of 2.7%.
• China: Valued at USD 545.8 million in 2025, expected to touch USD 729.3 million by 2034, growing at a CAGR of 3.3%.
• India: Estimated at USD 386.9 million in 2025, projected to reach USD 527.8 million by 2034, showing the fastest CAGR of 3.6%.

CT Angiography Devices: hold approximately 33% of market share, driven by faster scan times and high-resolution cross-sectional imaging. With 256-slice CT scanners now capable of capturing complete heart images in under 0.25 seconds, adoption rates have grown steadily, especially in emergency departments and trauma centers.

The CT Angiography Devices segment is valued at USD 4,113.5 million in 2025, forecasted to hit USD 5,668.4 million by 2034, representing a market share of 34.6% and a CAGR of 3.6%.

Top 5 Major Dominant Countries in the CT Angiography Devices Segment:

• United States: Holds USD 1,432.5 million in 2025, projected to reach USD 1,988.4 million by 2034, at a CAGR of 3.8%.
• China: Valued at USD 758.6 million in 2025, estimated to reach USD 1,084.3 million by 2034, growing at a CAGR of 3.9%.
• Germany: Market size at USD 490.8 million in 2025, likely to reach USD 657.7 million by 2034, expanding at a CAGR of 3.2%.
• Japan: Reaches USD 418.2 million in 2025, increasing to USD 578.6 million by 2034, with a CAGR of 3.5%.
• United Kingdom: Estimated at USD 356.7 million in 2025, growing to USD 495.9 million by 2034, achieving a CAGR of 3.7%.

MR Angiography Devices: accounts for nearly 30% of the total angiography market. It offers radiation-free imaging, making it suitable for younger and high-risk patient populations. The adoption rate of MR angiography increased by 29% between 2020 and 2024 due to improved magnetic field gradients and contrast-free imaging sequences.

The MR Angiography Devices segment is expected to record USD 2,158.0 million in 2025, projected to reach USD 2,867.3 million by 2034, with a CAGR of 3.1% and a market share of 18.2%.

Top 5 Major Dominant Countries in the MR Angiography Devices Segment:

• United States: Market size of USD 815.9 million in 2025, forecasted to reach USD 1,093.8 million by 2034, at a CAGR of 3.2%.
• Germany: Expected to reach USD 348.1 million in 2025 and grow to USD 456.2 million by 2034, at a CAGR of 3.0%.
• China: Holds USD 311.2 million in 2025, estimated to reach USD 423.5 million by 2034, growing at a CAGR of 3.4%.
• Japan: Projected to grow from USD 275.3 million in 2025 to USD 363.7 million by 2034, expanding at a CAGR of 3.1%.
• France: Estimated at USD 218.9 million in 2025, reaching USD 286.1 million by 2034, with a CAGR of 3.0%.

BY APPLICATION

Diagnostic: angiography holds approximately 61% of the total market, driven by increased cardiovascular screening programs and early detection initiatives. Over 15 million diagnostic angiography procedures were conducted globally in 2024, representing a 22% increase from 2019.

The Diagnostic Application dominates the market with a value of USD 9,326.5 million in 2025, projected to reach USD 12,144.9 million by 2034, maintaining a CAGR of 3.0% and representing nearly 78.5% market share.

Top 5 Major Dominant Countries in the Diagnostic Application:

• United States: USD 3,142.8 million in 2025, estimated to reach USD 4,100.2 million by 2034, growing at a CAGR of 3.1%.
• Germany: USD 1,012.5 million in 2025, forecasted to hit USD 1,348.9 million by 2034, with a CAGR of 3.0%.
• China: USD 858.7 million in 2025, projected to reach USD 1,187.6 million by 2034, at a CAGR of 3.3%.
• Japan: USD 769.2 million in 2025, expected to reach USD 1,024.8 million by 2034, with a CAGR of 3.1%.
• India: USD 594.1 million in 2025, likely to reach USD 810.3 million by 2034, expanding at a CAGR of 3.4%.

Therapeutic: angiography contributes around 39% of market share. It plays a vital role in guiding stent placement, embolization, and endovascular interventions. The number of interventional angiographic procedures has grown by 34% over the past five years, emphasizing its clinical significance.

The Therapeutic Application is valued at USD 2,557.4 million in 2025, expected to grow to USD 3,453.2 million by 2034, registering a CAGR of 3.3% and a market share of 21.5%.

Top 5 Major Dominant Countries in the Therapeutic Application:

• United States: USD 914.7 million in 2025, projected to reach USD 1,246.5 million by 2034, at a CAGR of 3.4%.
• China: USD 512.3 million in 2025, estimated to reach USD 709.8 million by 2034, with a CAGR of 3.6%.
• Germany: USD 369.8 million in 2025, growing to USD 492.1 million by 2034, expanding at a CAGR of 3.1%.
• Japan: USD 324.6 million in 2025, forecasted to reach USD 433.5 million by 2034, with a CAGR of 3.2%.
• United Kingdom: USD 270.6 million in 2025, likely to reach USD 366.4 million by 2034, recording a CAGR of 3.4%.

Angiography Device Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

holds approximately 33% of the global market share for angiography devices. The region benefits from advanced healthcare infrastructure, high per capita healthcare spending, and widespread availability of cutting-edge imaging systems. The U.S. alone contributes about 94% of the regional demand, supported by an estimated 1,900 cardiac catheterization labs. Canada also exhibits steady adoption, with 85% of tertiary hospitals operating angiography suites.

The North America Angiography Device Market is valued at USD 4,317.5 million in 2025, forecasted to reach USD 5,594.7 million by 2034, with a CAGR of 3.0%, accounting for nearly 36.3% of the global share.

North America – Major Dominant Countries in the “Angiography Device Market”:

• United States: USD 3,210.2 million in 2025, projected to reach USD 4,171.3 million by 2034, expanding at a CAGR of 3.1%.
• Canada: USD 628.9 million in 2025, likely to reach USD 827.5 million by 2034, with a CAGR of 3.1%.
• Mexico: USD 478.4 million in 2025, growing to USD 596.4 million by 2034, with a CAGR of 2.5%.
• Cuba: USD 32.1 million in 2025, reaching USD 40.7 million by 2034, with a CAGR of 2.7%.
• Panama: USD 25.6 million in 2025, expected to reach USD 33.3 million by 2034, showing a CAGR of 3.0%.

EUROPE

represents around 27% of the global angiography device market. Germany, the U.K., and France collectively account for nearly 60% of Europe’s angiography installations. The region has over 3,000 angiography labs, with approximately 72% upgraded to digital and hybrid imaging technologies. Initiatives to reduce stroke mortality—responsible for 11% of European deaths annually—drive adoption of neurovascular angiography systems. The demand for MR angiography is particularly strong, with installation rates increasing by 24% from 2020 to 2024.

The Europe Angiography Device Market holds a market size of USD 3,196.8 million in 2025, anticipated to reach USD 4,238.2 million by 2034, registering a CAGR of 3.2% and representing nearly 26.9% global market share.

Europe – Major Dominant Countries in the “Angiography Device Market”:

• Germany: USD 986.4 million in 2025, expected to grow to USD 1,316.7 million by 2034, at a CAGR of 3.2%.
• France: USD 698.3 million in 2025, projected to hit USD 934.8 million by 2034, with a CAGR of 3.3%.
• United Kingdom: USD 524.8 million in 2025, estimated to reach USD 701.1 million by 2034, expanding at a CAGR of 3.4%.
• Italy: USD 488.6 million in 2025, growing to USD 645.8 million by 2034, with a CAGR of 3.2%.
• Spain: USD 398.7 million in 2025, forecasted to reach USD 523.2 million by 2034, with a CAGR of 3.1%.

ASIA-PACIFIC

accounts for roughly 28% of the global market and is witnessing the fastest installation growth. China and India are leading contributors, representing over 65% of the regional demand. In 2024 alone, the region added more than 1,200 angiography systems, driven by expanding hospital infrastructure and public health initiatives targeting cardiovascular disease. Japan and South Korea maintain high technological sophistication, with nearly 88% of angiography systems being digital.

The Asia Angiography Device Market is valued at USD 2,896.3 million in 2025, expected to reach USD 4,142.5 million by 2034, with a CAGR of 3.9%, making it the fastest-growing regional market.

Asia – Major Dominant Countries in the “Angiography Device Market”:

• China: USD 1,032.7 million in 2025, estimated to hit USD 1,461.9 million by 2034, at a CAGR of 3.9%.
• Japan: USD 895.4 million in 2025, projected to reach USD 1,232.1 million by 2034, growing at a CAGR of 3.6%.
• India: USD 648.5 million in 2025, likely to reach USD 932.7 million by 2034, at a CAGR of 4.0%.
• South Korea: USD 232.3 million in 2025, forecasted to reach USD 323.2 million by 2034, with a CAGR of 3.7%.
• Singapore: USD 87.4 million in 2025, expected to reach USD 117.9 million by 2034, with a CAGR of 3.4%.

MIDDLE EAST & AFRICA

region contributes about 12% to global angiography device demand. The Gulf Cooperation Council (GCC) countries dominate this share, accounting for 70% of the regional installations. Saudi Arabia, the UAE, and Qatar are rapidly investing in advanced cardiac imaging centers, with over 250 angiography units installed by 2024. Africa’s adoption remains lower but is improving through donor-funded programs and private-sector partnerships.

The Middle East and Africa Angiography Device Market stands at USD 1,473.3 million in 2025, forecasted to reach USD 1,915.7 million by 2034, growing at a CAGR of 2.9%, accounting for 9.5% of global market share.

Middle East and Africa – Major Dominant Countries in the “Angiography Device Market”:

• Saudi Arabia: USD 498.7 million in 2025, projected to reach USD 648.4 million by 2034, at a CAGR of 2.9%.
• United Arab Emirates: USD 354.2 million in 2025, expected to reach USD 470.1 million by 2034, at a CAGR of 3.0%.
• South Africa: USD 261.8 million in 2025, forecasted to hit USD 343.6 million by 2034, with a CAGR of 2.8%.
• Qatar: USD 195.7 million in 2025, growing to USD 258.2 million by 2034, recording a CAGR of 3.0%.
• Egypt: USD 162.9 million in 2025, projected to reach USD 195.4 million by 2034, at a CAGR of 2.6%.

List of Top Angiography Device Companies

• GE Healthcare
• Siemens Healthcare
• Toshiba Corporation
• Medtronic
• Jude
• Abbott
• Boston Scientific Corporation
• Cordis Corporation
• Philips Healthcare
• Shimadzu Corporation

GE Healthcare – Holds approximately 18% of the global angiography device market, supported by its strong product portfolio in digital imaging and hybrid systems.

Siemens Healthcare – Accounts for around 16% market share, driven by its Artis series angiography systems and strong presence in North America and Europe.

Investment Analysis and Opportunities

Investment in the Angiography Device Market is being driven by the rising need for advanced cardiovascular diagnostics and therapeutic interventions. Healthcare institutions worldwide have increased their imaging equipment budgets by 22% since 2020, with angiography devices being a top priority. Approximately 45% of hospitals plan to upgrade to AI-enabled angiography platforms within the next three years. Emerging markets such as India, China, and Brazil offer strong investment potential, where government-backed healthcare expansion programs aim to install over 2,500 new systems by 2026. Venture capital investments in angiography-focused startups have grown by 38% since 2021, indicating growing investor confidence.

There is a significant opportunity in the integration of robotic-assisted angiography, projected to increase procedural precision by 35% and reduce complication rates by 27%. Furthermore, investments in cloud-based imaging storage and tele-angiography platforms are reshaping healthcare delivery, enabling remote consultations and real-time analysis. Manufacturers are focusing on energy-efficient and portable devices, reducing power consumption by up to 30%, making them suitable for resource-limited healthcare settings. Hospitals are also increasingly entering into long-term service contracts, representing about 18% of total capital expenditure. The market’s high equipment replacement rate—estimated at 5–6 years per system—presents recurring revenue and reinvestment opportunities for manufacturers.

New Product Development

Innovation is a core growth pillar in the angiography device industry. Between 2023 and 2025, more than 45 new angiography models have been launched globally, incorporating AI-driven image enhancement, dose management, and advanced 3D reconstruction capabilities. Manufacturers are focusing on enhancing image resolution by 50% and reducing examination time by up to 25%. The development of dual-energy CT angiography enables superior tissue differentiation and better visualization of calcified plaques. Additionally, zero-contrast MR angiography is gaining momentum, with adoption increasing by 29% in the past two years. Companies are also introducing compact mobile angiography systems weighing under 100 kg, designed for intensive care and emergency settings.

Software integration has advanced significantly; around 40% of new systems launched in 2024 featured real-time data analytics and cloud connectivity. Modular system design now allows healthcare providers to customize imaging setups for coronary, neurovascular, or peripheral angiography applications. Product development is also emphasizing patient comfort and radiation safety. The latest angiography systems can reduce radiation exposure by up to 55%, aligning with international safety standards. Manufacturers are also focusing on integrating voice-controlled interfaces, improving workflow efficiency by 20–25% and enhancing procedural ergonomics for clinicians.

Five Recent Developments

• A leading manufacturer launched an AI-assisted angiography suite reducing diagnostic time by 40% in 2023.
• A new portable digital angiography system weighing 90 kg was introduced in 2024 for mobile cardiac units.
• A robotic-assisted angiography platform achieved 35% faster intervention speed and improved stent placement precision in 2024.
• In 2025, hybrid angiography labs combining CT and X-ray imaging increased procedural efficiency by 32%.
• Introduction of contrast-free MR angiography protocols improved safety for 18% of patients with renal complications in 2025.

Report Coverage of the Angiography Device Market

The Angiography Device Market Report provides comprehensive analysis covering product types, applications, regional dynamics, and competitive strategies across global, regional, and local levels. The report assesses installation base data, equipment upgrade cycles, and procedural volumes, which exceed 15 million diagnostic and therapeutic angiography procedures annually. It examines technological advancements, such as AI-based imaging, 3D visualization, robotic assistance, and low-dose radiation systems. Approximately 42% of hospitals globally are in the process of upgrading angiography systems to newer models introduced after 2022. The Angiography Device Market Research Report evaluates major segments by technology—X-ray, CT, and MR angiography—and by application, including diagnostic and therapeutic use.

The analysis includes insights into end-user distribution, showing hospitals with 68% share, diagnostic centers with 24%, and ambulatory surgical centers with 8%. Regionally, the report covers North America (33%), Europe (27%), Asia-Pacific (28%), and Middle East & Africa (12%). The Angiography Device Market Forecast anticipates continued system replacements, with a focus on hybrid operating rooms and AI integration. Furthermore, the report identifies key Angiography Device Market Opportunities in emerging economies, particularly in Asia-Pacific, where demand for affordable, compact angiography systems is increasing. It also highlights the role of top manufacturers—GE Healthcare and Siemens Healthcare—who together hold 34% of global market share, demonstrating strong leadership through consistent innovation and broad product portfolios.

Angiography Device Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 12252.3 Million in 2026
Market Size Value By	USD 16126.7 Million by 2035
Growth Rate	CAGR of 3.1% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : X-Ray Angiography Devices CT Angiography Devices MR Angiography Devices By Application : Diagnostic Therapeutic
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample